Caudal dexmedetomedine versus magnesium sulphate added to bupivacaine for caudal block in pediatric infra-umbilical orthopedic surgeries :

Caudal dexmedetomedine versus magnesium sulphate added to bupivacaine for caudal block in pediatric infra-umbilical orthopedic surgeries : randomized controlled study.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR201807487797587

Enrollment

Registered

2018-07-11

Start date

2018-07-12

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paediatrics Orthopaedics

Interventions

caudal bupivacaine

dexmetedomedine group

magnesium group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: a. Age between 1 - 7 years old. b. American Society of Anesthesiologist (ASA) physical status class I- II. c. Patients scheduled for infra-umbilical orthopedic surgeries.

Exclusion criteria

Exclusion criteria: a. Patients with known allergy to the study drugs. b. Suspected coagulopathy. c. Infection at the site of caudal block d. History of developmental delay or neuromuscular disorders. e. Skeletal deformities. f. Patients on magnesium therapy

Design outcomes

Primary

Measure	Time frame
•To evaluate the effect of dexmetedomidine in comparison to magnesium sulphate on duration of bupivacaine caudal block.	—

Secondary

Measure	Time frame
To evaluate the difference between dexmetedomidine and magnesium as an adjuvant in caudal block in hemodynamics(MBP,HR) and post operative pain intensity(FLACC score).	—

Countries

Egypt

Contacts

Public Contactamira elkhateeb

lecturer

amira_khateeb@yahoo.com01223955087

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026